Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yu Hara
Observed names:
Y Hara,
Y. Hara,
Y., Hara,
YU HARA,
Yoshinori Hara,
Yu HARA
show all 6
Institution:
Yokohama City University
Observed institutions:
Yokohama City University Medical Center,
National Defense Medical College Hospital,
Yokohama City University Hospital,
Okayama University Hospital,
Kanagawa Cardiovascular and Respiratory Center,
Ofuna Chuo Hospital,
National Defense Medical College,
Yokohama City University
show all 8
ORCID:
0000-0002-2574-2516
Observed ORCID:
0000-0002-2574-2516
OpenAlex ID:
A5073290799
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
2019
·
Luis Paz-Ares
, Mikhail Dvorkin
, et al.
·
The Lancet
·
2,281
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
2020
·
Jonathan W Goldman
, Mikhail Dvorkin
, et al.
·
The Lancet Oncology
·
688
Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis
2021
·
Hao Chen
, Hiromi Matsumoto
, et al.
·
Scientific Reports
·
76
PDF
Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study
2022
·
Rod Hughes
, Eleni Rapsomaniki
, et al.
·
Respiratory Medicine
·
47
PDF
Clinical significance of Charlson comorbidity index as a prognostic parameter for patients with acute or subacute idiopathic interstitial pneumonias and acute exacerbation of collagen vascular diseases-related interstitial pneumonia
2019
·
Kota Murohashi
, Yu Hara
, et al.
·
Journal of Thoracic Disease
·
35
PDF
Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment
2011
·
Yutaka Inaba
, Remi Ozawa
, et al.
·
Annals of the Rheumatic Diseases
·
34
Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer
2017
·
Takahisa Eriguchi
, Atsuya Takeda
, et al.
·
Lung Cancer
·
33
Clinical utility of a composite scoring system including Charlson Comorbidity Index score in patients with interstitial lung disease
2020
·
Hiroyuki Yagyu
, Kota Murohashi
, et al.
·
Journal of Thoracic Disease
·
29
PDF
Pleuroparenchymal Fibroelastosis as a Series of Airway Complications Associated with Chronic Graft-versus-host Disease following Allogeneic Bone Marrow Transplantation
2013
·
Yuji Fujikura
, Soichiro Kanoh
, et al.
·
Internal Medicine
·
28
PDF
Adverse events induced by nivolumab and ipilimumab combination regimens
2022
·
Kohei Somekawa
, Nobuyuki Horita
, et al.
·
Therapeutic Advances in Medical Oncology
·
27
Benefit-Risk Profile of P2X3 Receptor Antagonists for Treatment of Chronic Cough
2024
·
Shota Yamamoto
, Nobuyuki Horita
, et al.
·
CHEST Journal
·
25
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD
2023
·
Erin L. Tomaszewski
, Mark J. Atkinson
, et al.
·
Respiratory Research
·
25
PDF
Arterial Carboxyhemoglobin Measurement Is Useful for Evaluating Pulmonary Inflammation in Subjects with Interstitial Lung Disease
2017
·
Yu Hara
, Masaharu Shinkai
, et al.
·
Internal Medicine
·
22
PDF
MicroRNA ‐200b is a potential biomarker of the expression of PD‐L1 in patients with lung cancer
2020
·
Seigo Katakura
, Nobuaki Kobayashi
, et al.
·
Thoracic Cancer
·
21
PDF
Declined Functional Status Prolonged Hospital Stay for Community-Acquired Pneumonia in Seniors
2020
·
Hao Chen
, Yu Hara
, et al.
·
Clinical Interventions in Aging
·
21
PDF
The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study
2022
·
Sarowar Muhammad Golam
, Christer Janson
, et al.
·
Respiratory Medicine
·
20
PDF
Stereotactic body radiotherapy for lung cancer patients with idiopathic interstitial pneumonias
2017
·
Yuichiro Tsurugai
, Atsuya Takeda
, et al.
·
Radiotherapy and Oncology
·
20
Identification of Biomarkers for Non–small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor
2020
·
SOUSUKE KUBO
, NOBUAKI KOBAYASHI
, et al.
·
Anticancer Research
·
19
PDF
Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non‐small cell lung cancer patients: A meta‐analysis
2021
·
Nobuaki Kobayashi
, Seigo Katakura
, et al.
·
Thoracic Cancer
·
17
PDF
Acute eosinophilic pneumonia caused by camostat mesilate: The first case report
2016
·
Shinichiro Ota
, Yu Hara
, et al.
·
Respiratory Medicine Case Reports
·
17
PDF
The Effectiveness and Safety of Long-Term Macrolide Therapy for COPD in Stable Status: A Systematic Review and Meta-Analysis
2023
·
Kazunori Nakamura
, Yukio Fujita
, et al.
·
Diseases
·
16
PDF
Heme oxygenase-1 as an important predictor of the severity of COVID-19
2022
·
Yu Hara
, Jun Tsukiji
, et al.
·
PLoS ONE
·
16
Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial
2021
·
Hiromi Matsumoto
, Nobuaki Kobayashi
, et al.
·
Thoracic Cancer
·
16
Serum heme oxygenase-1 measurement is useful for evaluating disease activity and outcomes in patients with acute respiratory distress syndrome and acute exacerbation of interstitial lung disease
2020
·
Ryo Nagasawa
, Yu Hara
, et al.
·
BMC Pulmonary Medicine
·
16
PDF
Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan
2020
·
Seigo Katakura
, Nobuaki Kobayashi
, et al.
·
Tuberculosis
·
15
Show more works
View as search
Works count:
134
Citation count:
4,107
H-index:
18
I10-index:
47
Year
Topic
Type
